News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
Hengrui Pharmaceuticals (01276.HK) SHR-A1811 Included in Breakthrough Therapy Designation List
Hengrui Pharmaceuticals (01276.HK) announced that SHR-A1811 for injection, developed by its subsidiary Suzhou Shengdiya, has been included in the Breakthrough Therapy Designation l...
Reset
Send
The window will close in 5 seconds
Hengrui Pharmaceuticals (01276.HK) SHR-A1811 Included in Breakthrough Therapy Designation List
Close
Recommend
4
Positive
5
Negative
0
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

Hengrui Pharmaceuticals (01276.HK)  -0.050 (-0.075%)    Short selling $44.23M; Ratio 45.817%   announced that SHR-A1811 for injection, developed by its subsidiary Suzhou Shengdiya, has been included in the Breakthrough Therapy Designation list by the Center for Drug Evaluation of the National Medical Products Administration. The proposed indication is for use in combination with pertuzumab for the treatment of patients with human epidermal growth factor receptor 2 (HER2)-positive recurrent or metastatic breast cancer. For recurrent/metastatic disease, patients should not have previously received anti-HER2 therapy. This marks the 11th indication for which SHR-A1811 has received Breakthrough Therapy Designation. (de/d)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-22 16:25.)



Related News JIANGSU HENGRUI PHARMACEUTICALS (01276.HK) 1Q Net Profit Attributable to Shareholders Up 21.78% YoY
This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

Auto-translated by AI
View Original Text

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.